Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 19/20 | 0.42 |
| ▸ | BCAT2 | O15382 | 17/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21653880 | 0.87 | BCAT1 (0.40) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL28359249 | 0.86 | BCAT1 (0.39) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL23698930 | 0.86 | BCAT1 (0.46) | BCAT1BCAT2HSD17B10 | |
| SCHEMBL21816909 | 0.85 | BCAT1 (0.40) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL21635543 | 0.84 | BCAT1 (0.42) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL30678042 | 0.84 | BCAT1 (0.42) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL29692316 | 0.84 | BCAT1 (0.42) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL27307569 | 0.84 | BCAT1 (0.42) | BCAT1BCAT2MAPTTSHRHSD17B10 | |
| SCHEMBL21635546 | 0.83 | BCAT1 (0.41) | BCAT1BCAT2 | |
| SCHEMBL25061754 | 0.80 | BCAT1 (0.38) | BCAT1BCAT2MAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110964001-B | Method for preparing isoxazoline-containing uracil compound through methylation | 沈阳中化农药化工研发有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-105753853-B | Isoxazoline-containing uracil compound and application thereof | 沈阳中化农药化工研发有限公司 | 2020-08-04 | — | — | CN | disclosed |
| CN-110964001-A | Method for preparing isoxazoline-containing uracil compounds through methylation | 沈阳中化农药化工研发有限公司 | 2020-04-07 | — | — | CN | disclosed |
| WO-2020063613-A1 | METHOD FOR PREPARING ISOXAZOLINE-CONTAINING URACIL COMPOUND BY METHYLATION | 沈阳中化农药化工研发有限公司 | 2020-04-02 | — | — | WO | disclosed |
| CN-106536517-B | Isoxazoline-containing uracil compound and application thereof | 沈阳中化农药化工研发有限公司 | 2020-03-17 | — | — | CN | disclosed |
| US-10550111-B2 | Pyrimidine urea compound containing isoxazolines and use thereof | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2020-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550111-B2 | Pyrimidine urea compound containing isoxazolines and use thereof | DDX6, OAT, DHX36 | BCAT1 2789/4885BCAT2 2976/4885MAPT 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.